Investor relations need to be more proactive. The current consultant is not adding much value for his monthly retainer. The quarterly webinars are the only activity taking place. In these you have to type in your questions while the presentation is underway and the consultant may or may not let your question through. Then the presentations are not released.
Microcap’s need to out and about. SDV should be presenting at the Australian Microcap Investment Conference that is being held this week. The former MD was good at it and also in providing regular ASX releases. Once the current Chairman came on board investor relations activity slowed considerably. You can’t blame the current CEO, who not long ago was running a private company and is now running a ASX listed company with global operations.
I would like to understand the quantum of the growth possibilities for PFAS treatment in Europe and North America. PFAS treatment is where the higher margins are. There is also no broker support in the market. One approach maybe to raise capital and get that support.
SDV Price at posting:
24.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)